Page last updated: 2024-10-31

apnea and Retrolental Fibroplasia

apnea has been researched along with Retrolental Fibroplasia in 45 studies

Apnea: A transient absence of spontaneous respiration.

Research Excerpts

ExcerptRelevanceReference
"We randomly assigned 2006 infants with birth weights of 500 to 1250 g to receive either caffeine or placebo until therapy for apnea of prematurity was no longer needed."9.12Long-term effects of caffeine therapy for apnea of prematurity. ( Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2007)
"To determine the incidence and risk factors of postoperative apnea in premature infants who received general anesthesia for cryotherapy or laser photocoagulation for treatment of retinopathy of prematurity (ROP) at Queen Sirikit National Institute of Child Health."7.80The incidence and risk factors of apnea in premature infants underwent general anesthesia for cryotherapy or laser photocoagulation for treatment of retinopathy of prematurity at Queen Sirikit National Institute of Child Health. ( Attachoo, A; Chongarunngamsang, W; Horatanaruang, D; Lauhsattana, S, 2014)
" The infants developed severe apnea and bradycardia at the end of the ROP examinations."7.75Apnea and bradycardia in two premature infants during routine outpatient retinopathy of prematurity screening. ( Kaufman, LM; Wood, MG, 2009)
"Growth, neurologic, and ophthalmologic assessments were done in 21 low-birth-weight infants given caffeine for neonatal apnea and in 21 matched control infants."7.66Sequelae of caffeine treatment in preterm infants with apnea. ( Aranda, JV; Gunn, TR; Metrakos, K; Riley, P; Willis, D, 1979)
"We randomly assigned 2006 infants with birth weights of 500 to 1250 g to receive either caffeine or placebo until therapy for apnea of prematurity was no longer needed."5.12Long-term effects of caffeine therapy for apnea of prematurity. ( Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2007)
" Infants in the restrictive-transfusion group were more likely to have intraparenchymal brain hemorrhage or periventricular leukomalacia, and they had more frequent episodes of apnea, including both mild and severe episodes."5.11Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. ( Bell, EF; Cress, GA; Johnson, KJ; Kromer, IJ; Mahoney, LT; Mock, DM; Seward, VJ; Strauss, RG; Widness, JA; Zimmerman, MB, 2005)
", a possible improved cognition of infants at 18-21 months' corrected age and a reduction of apnea."5.01What Is New about Transfusions for Preterm Infants? An Update. ( Kirpalani, H; Whyte, RK, 2019)
"Apnea of prematurity (AOP) is a common and pervasive problem in very low birth weight infants."4.98Caffeine: an evidence-based success story in VLBW pharmacotherapy. ( Dobson, NR; Hunt, CE, 2018)
" Despite aggressive respiratory support including mechanical ventilation, continuous positive airway pressure, oxygen and caffeine therapy to reduce apnea and accompanying intermittent hypoxemia, the incidence of intermittent hypoxemia events continues to increase during the first few months of life."4.93Cardiorespiratory events in preterm infants: interventions and consequences. ( Di Fiore, JM; Gauda, E; MacFarlane, P; Martin, RJ; Poets, CF, 2016)
"Premature infants often have serious problems, such as anemia, retinopathy, hearing loss and apnea, before and after discharge from the neonatal intensive care unit."4.78The neonatal ICU graduate: Part I. Common problems. ( Hulseman, ML; Norman, LA, 1992)
" Premature infants often require outpatient care for bronchopulmonary dysplasia, apnea, retinopathy of prematurity, intraventricular hemorrhage, hearing loss, hypothyroxinemia, anemia, neurodevelopmental sequelae, assessment of growth and nutrition, immunizations, and psychosocial stress."4.77Continuing care for the preterm infant after dismissal from the neonatal intensive care unit. ( Berseth, CL; Swanson, JA, 1987)
" These factors (immaturity, hyperoxia, hypoxia, blood transfusions, intraventricular hemorrhage, apnea, infection, hypercarbia, hypocarbia, patent ductus arteriosus, prostaglandin synthetase inhibitors, vitamin E deficiency, lactic acidosis, prenatal complications, genetic factors) may all be present in an infant."4.76A reexamination of the role of oxygen in retrolental fibroplasia. ( Dangman, B; Lucey, JF, 1984)
"346), apnea (OR = 2."3.88Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors. ( Mu, D; Qu, Y; Tong, Y; Wu, T; Xia, B; Zhang, L, 2018)
" Caffeine is frequently used for apnea of prematurity."3.83Atrial arrhythmia after newborn eye exam, to caffeine or not to caffeine? ( Ahmad, A; Klein, B; Mondal, T, 2016)
"To determine the incidence and risk factors of postoperative apnea in premature infants who received general anesthesia for cryotherapy or laser photocoagulation for treatment of retinopathy of prematurity (ROP) at Queen Sirikit National Institute of Child Health."3.80The incidence and risk factors of apnea in premature infants underwent general anesthesia for cryotherapy or laser photocoagulation for treatment of retinopathy of prematurity at Queen Sirikit National Institute of Child Health. ( Attachoo, A; Chongarunngamsang, W; Horatanaruang, D; Lauhsattana, S, 2014)
"When asked to address the above question, findings that appeared to be among the most relevant included (1) interventions in the delivery room directed at supporting the physiological transition from intrauterine to extrauterine life rather than actively intervening in it; (2) recent data suggesting that keeping extremely low-gestational age neonates at a pulse oximeter saturation (SpO(2)) of 91-95% would increase their chances of survival compared with aiming for lower SpO(2) values; (3) using caffeine citrate in infants <1250 g with apnoea of prematurity improves neurodevelopmental outcome; (4) injecting antivascular epithelial growth factor into the vitreous seems to be an effective treatment for retinopathy of prematurity and (5) moderate hypothermia for perinatal hypoxic-ischaemic encephalopathy increases the likelihood of survival without neurological impairment."3.79What are the main research findings during the last 5 years that have changed my approach to clinical practice? ( Poets, CF, 2013)
"Apnea events increased significantly (P = ."3.77Physiologic effects of retinopathy of prematurity screening examinations. ( Green, A; Jeffs, DA; Mitchell, AJ; Roberson, PK, 2011)
"001), apnea (P=0."3.75Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome. ( Chaudhari, S; Kadam, S; Kamat, A; Patwardhan, V; Vaidya, U, 2009)
" The infants developed severe apnea and bradycardia at the end of the ROP examinations."3.75Apnea and bradycardia in two premature infants during routine outpatient retinopathy of prematurity screening. ( Kaufman, LM; Wood, MG, 2009)
" On univariate analysis, gestation < or = 32 weeks, anemia, Blood transfusions, apnea and exposure to oxygen significantly increased the risk of developing ROP."3.69Retinopathy of prematurity: incidence and risk factors. ( Battu, RR; Rekha, S, 1996)
" For the 12 procedures performed on 11 infants who were not being mechanically ventilated at the time of cryotherapy, four infants had no complications, three infants had minor respiratory deteriorations, and five infants required positive pressure ventilation for severe apnea and bradycardia episodes (one just after narcotic administration, four during the procedure)."3.68Respiratory complications associated with cryotherapy in premature infants. ( Batton, DG; Ivery, P; Trese, M, 1992)
" Of 32 possible risk factors examined, the factors significantly associated with ROP were: apnea with mask and bag ventilation; prolonged parenteral nutrition; number of blood transfusions; and episodes of hypoxemia, hypercarbia, and hypocarbia."3.66Retinopathy of prematurity: incidence and risk factors. ( Ben-Sira, I; Krikler, R; Nissenkorn, I; Reisner, SH; Shohat, M; Yassur, Y, 1983)
"001); apnea requiring bag and mask resuscitation with oxygen (P less than ."3.66Risk factors in retrolental fibroplasia. ( Aranda, JV; Easdown, J; Gunn, TR; Outerbridge, EW, 1980)
"Growth, neurologic, and ophthalmologic assessments were done in 21 low-birth-weight infants given caffeine for neonatal apnea and in 21 matched control infants."3.66Sequelae of caffeine treatment in preterm infants with apnea. ( Aranda, JV; Gunn, TR; Metrakos, K; Riley, P; Willis, D, 1979)
"Retinopathy of prematurity was detected in 10."1.35Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. ( Chen, Y; Gilbert, C; Jiang, YR; Li, XX; Liang, JH; Yin, H; Zhao, MW, 2008)
"Vomiting was present in 4% of the newborns, gastric aspirates in 22% and apnoeas in 41% after the examination."1.32Screening for retinopathy of prematurity: is it painful? ( Belda, S; De la Cruz, J; Pallás, CR; Tejada, P, 2004)
"Retrolental fibroplasia is a condition that principally affects low birth weight premature babies in whom oxygen therapy has not been adequately controlled."1.26[Present status of retrolental fibroplasia in France]. ( Bethenod, M; Gerhard, JP; Messer, J; Willard, D, 1979)

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-199019 (42.22)18.7374
1990's5 (11.11)18.2507
2000's9 (20.00)29.6817
2010's12 (26.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, T1
Zhang, L1
Tong, Y1
Qu, Y1
Xia, B1
Mu, D1
Dobson, NR1
Hunt, CE1
Tan, JBC1
Dunbar, J1
Hopper, A1
Wilson, CG1
Angeles, DM1
Kirpalani, H1
Whyte, RK1
Zhang, Q1
Zhao, H1
Feng, Y1
Attachoo, A1
Horatanaruang, D1
Chongarunngamsang, W1
Lauhsattana, S1
Di Fiore, JM1
Poets, CF2
Gauda, E1
Martin, RJ1
MacFarlane, P1
Reid, B1
Wang, H1
Guillet, R1
Macintosh, JLB1
Huggins, LJ1
Eden, LM1
Merrill, KC1
Luthy, KEB1
Ahmad, A1
Mondal, T1
Klein, B1
Chaudhari, S1
Patwardhan, V1
Vaidya, U1
Kadam, S1
Kamat, A1
Wood, MG1
Kaufman, LM1
Mitchell, AJ1
Green, A1
Jeffs, DA1
Roberson, PK1
TIZARD, JP2
Kim, TI1
Sohn, J1
Pi, SY1
Yoon, YH1
Belda, S1
Pallás, CR1
De la Cruz, J1
Tejada, P1
Gupta, VP1
Dhaliwal, U1
Sharma, R1
Gupta, P1
Rohatgi, J1
Bell, EF1
Strauss, RG1
Widness, JA1
Mahoney, LT1
Mock, DM1
Seward, VJ1
Cress, GA1
Johnson, KJ1
Kromer, IJ1
Zimmerman, MB1
Schmidt, B1
Roberts, RS1
Davis, P1
Doyle, LW1
Barrington, KJ1
Ohlsson, A1
Solimano, A1
Tin, W1
Stevenson, DK1
Chen, Y1
Li, XX1
Yin, H1
Gilbert, C1
Liang, JH1
Jiang, YR1
Zhao, MW1
Shohat, M1
Reisner, SH1
Krikler, R1
Nissenkorn, I1
Yassur, Y1
Ben-Sira, I1
Lucey, JF1
Dangman, B1
François, J1
Flynn, JT1
Gunn, TR2
Easdown, J1
Outerbridge, EW2
Aranda, JV3
Clark, C1
Gibbs, JA1
Maniello, R1
Rekha, S1
Battu, RR1
Jones, MD1
Murton, LJ1
Metrakos, K1
Riley, P1
Willis, D1
Messer, J1
Bethenod, M1
Gerhard, JP1
Willard, D1
Fitzhardinge, PM1
Pape, P1
Arstikaitis, M1
Boyle, M1
Ashby, S1
Rowley, A1
Netley, C1
Swyer, PR1
Immonen, I1
Hulseman, ML1
Norman, LA1
Batton, DG1
Ivery, P1
Trese, M1
Tashiro, C1
Matsui, Y1
Nakano, S1
Ueyama, H1
Nishimura, M1
Oka, N1
Levitt, GA1
Mushin, A2
Bellman, S1
Harvey, DR1
Purohit, DM1
Ellison, RC1
Zierler, S1
Miettinen, OS1
Nadas, AS1
Swanson, JA1
Berseth, CL1
Bates, JH1
Burnstine, RA1
Nicholson, A1
Bowell, R1
Gorman, WA1
Alden, ER1
Kalina, RE1
Hodson, WA1
Baum, JD1

Clinical Trials (10)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Apneic Oxygenation to Prevent Oxygen Desaturation During Intubation in the NICU[NCT05451953]110 participants (Anticipated)Interventional2022-07-21Recruiting
Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy[NCT03448640]60 participants (Actual)Observational2016-01-15Completed
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity: A Crossover Randomized Controlled Trial[NCT06067958]Phase 330 participants (Anticipated)Interventional2024-01-31Not yet recruiting
Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm Infants[NCT00369005]100 participants Interventional1992-12-31Completed
A Prospective, Controlled Trial of Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea of Prematurity[NCT01911182]Phase 2/Phase 37 participants (Actual)Interventional2011-10-31Terminated (stopped due to Low recruitment rate)
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants[NCT00182312]Phase 32,000 participants (Anticipated)Interventional1999-10-31Completed
Long-Term Effects On Sleep Of Methylxanthine Therapy For Apnea Of Prematurity[NCT01020357]Phase 3201 participants (Actual)Interventional2009-11-30Completed
[NCT01066728]Phase 2/Phase 387 participants (Actual)Interventional2001-08-31Completed
A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates[NCT03086473]Phase 424 participants (Actual)Interventional2017-02-01Active, not recruiting
Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784]Phase 118 participants (Anticipated)Interventional2024-06-30Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for apnea and Retrolental Fibroplasia

ArticleYear
Caffeine: an evidence-based success story in VLBW pharmacotherapy.
    Pediatric research, 2018, Volume: 84, Issue:3

    Topics: Apnea; Caffeine; Central Nervous System Stimulants; Ductus Arteriosus, Patent; Enterocolitis, Necrot

2018
What Is New about Transfusions for Preterm Infants? An Update.
    Neonatology, 2019, Volume: 115, Issue:4

    Topics: Anemia, Neonatal; Apnea; Erythrocyte Transfusion; Erythropoietin; Evidence-Based Practice; Humans; I

2019
Cardiorespiratory events in preterm infants: interventions and consequences.
    Journal of perinatology : official journal of the California Perinatal Association, 2016, Volume: 36, Issue:4

    Topics: Animals; Apnea; Bradycardia; Caffeine; Central Nervous System Stimulants; Continuous Positive Airway

2016
A reexamination of the role of oxygen in retrolental fibroplasia.
    Pediatrics, 1984, Volume: 73, Issue:1

    Topics: Anencephaly; Apnea; Carbon Dioxide; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Exchange Transfu

1984
Mechanical ventilation in newborn infants with hyaline membrane disease;.
    Pediatric annals, 1977, Volume: 6, Issue:4

    Topics: Acidosis; Apnea; Birth Weight; Bradycardia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Gestatio

1977
[Retinopathy of prematurity].
    Duodecim; laaketieteellinen aikakauskirja, 1991, Volume: 107, Issue:1

    Topics: Apnea; Humans; Hypercapnia; Hypocapnia; Infant, Newborn; Oxygen; Retinopathy of Prematurity

1991
The neonatal ICU graduate: Part I. Common problems.
    American family physician, 1992, Volume: 45, Issue:3

    Topics: Anemia; Apnea; Bronchopulmonary Dysplasia; Hearing Disorders; Humans; Infant; Infant, Low Birth Weig

1992
Continuing care for the preterm infant after dismissal from the neonatal intensive care unit.
    Mayo Clinic proceedings, 1987, Volume: 62, Issue:7

    Topics: Anemia, Neonatal; Apnea; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Hearing Loss; Humans; Infa

1987
Retrolental fibroplasia: management of oxygen therapy.
    British medical bulletin, 1970, Volume: 26, Issue:2

    Topics: Apnea; Brain Diseases; Humans; Hyaline Membrane Disease; Infant, Newborn; Intubation, Intratracheal;

1970

Trials

2 trials available for apnea and Retrolental Fibroplasia

ArticleYear
Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants.
    Pediatrics, 2005, Volume: 115, Issue:6

    Topics: Anemia; Apnea; Blood Donors; Brain Damage, Chronic; Bronchopulmonary Dysplasia; Cerebral Hemorrhage;

2005
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007
Long-term effects of caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Development

2007

Other Studies

34 other studies available for apnea and Retrolental Fibroplasia

ArticleYear
Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors.
    Investigative ophthalmology & visual science, 2018, 02-01, Volume: 59, Issue:2

    Topics: Apnea; Birth Weight; Blood Transfusion; Bronchopulmonary Dysplasia; China; Ductus Arteriosus, Patent

2018
Differential effects of the retinopathy of prematurity exam on the physiology of premature infants.
    Journal of perinatology : official journal of the California Perinatal Association, 2019, Volume: 39, Issue:5

    Topics: Apnea; Bradycardia; Female; Gastric Emptying; Heart Rate; Humans; Infant, Newborn; Infant, Premature

2019
Laryngeal mask airway with pressure support ventilation vs. endotracheal tube with pressure controlled ventilation in preterm infants undergoing ROP surgery: A propensity score matching analysis of perioperative complications.
    Journal of clinical anesthesia, 2019, Volume: 57

    Topics: Anesthesia, General; Apnea; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very

2019
The incidence and risk factors of apnea in premature infants underwent general anesthesia for cryotherapy or laser photocoagulation for treatment of retinopathy of prematurity at Queen Sirikit National Institute of Child Health.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2014, Volume: 97 Suppl 6

    Topics: Anesthesia, General; Apnea; Child; Cryotherapy; Female; Gestational Age; Humans; Incidence; Infant;

2014
Apnea after Routine Eye Examinations in Premature Infants.
    American journal of perinatology, 2017, Volume: 34, Issue:2

    Topics: Apnea; Birth Weight; Bradycardia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Ophth

2017
Immunization Status of NICU Graduates at a Tertiary Care Children's Hospital.
    Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2017, Volume: 17, Issue:2

    Topics: Adrenal Cortex Hormones; Age Factors; Apnea; Bradycardia; Bronchopulmonary Dysplasia; Continuous Pos

2017
Atrial arrhythmia after newborn eye exam, to caffeine or not to caffeine?
    Journal of neonatal-perinatal medicine, 2016, Volume: 9, Issue:4

    Topics: Apnea; Atrial Premature Complexes; Bradycardia; Caffeine; Central Nervous System Stimulants; Cyclope

2016
Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome.
    Indian pediatrics, 2009, Volume: 46, Issue:3

    Topics: Apnea; Birth Weight; Developing Countries; Female; Gestational Age; Humans; Incidence; India; Infant

2009
Apnea and bradycardia in two premature infants during routine outpatient retinopathy of prematurity screening.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2009, Volume: 13, Issue:5

    Topics: Apnea; Bradycardia; Diagnostic Techniques, Ophthalmological; Humans; Infant, Newborn; Neonatal Scree

2009
What are the main research findings during the last 5 years that have changed my approach to clinical practice?
    Archives of disease in childhood. Fetal and neonatal edition, 2013, Volume: 98, Issue:1

    Topics: Apnea; Caffeine; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Extremely Premature;

2013
Physiologic effects of retinopathy of prematurity screening examinations.
    Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2011, Volume: 11, Issue:4

    Topics: Academic Medical Centers; Apnea; Arkansas; Female; Health Status; Humans; Infant, Newborn; Intensive

2011
Physiologic effects of retinopathy of prematurity screening examinations.
    Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2011, Volume: 11, Issue:4

    Topics: Academic Medical Centers; Apnea; Arkansas; Female; Health Status; Humans; Infant, Newborn; Intensive

2011
Physiologic effects of retinopathy of prematurity screening examinations.
    Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2011, Volume: 11, Issue:4

    Topics: Academic Medical Centers; Apnea; Arkansas; Female; Health Status; Humans; Infant, Newborn; Intensive

2011
Physiologic effects of retinopathy of prematurity screening examinations.
    Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2011, Volume: 11, Issue:4

    Topics: Academic Medical Centers; Apnea; Arkansas; Female; Health Status; Humans; Infant, Newborn; Intensive

2011
INDICATIONS FOR OXYGEN THERAPY IN THE NEWBORN.
    Pediatrics, 1964, Volume: 34

    Topics: Apnea; Asphyxia Neonatorum; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Oxygen; Ox

1964
Postnatal risk factors of retinopathy of prematurity.
    Paediatric and perinatal epidemiology, 2004, Volume: 18, Issue:2

    Topics: Apnea; Birth Weight; Disease Progression; Gestational Age; Humans; Infant, Newborn; Infant, Prematur

2004
Screening for retinopathy of prematurity: is it painful?
    Biology of the neonate, 2004, Volume: 86, Issue:3

    Topics: Apnea; Birth Weight; Blood Pressure; Diagnostic Techniques, Ophthalmological; Gestational Age; Heart

2004
Retinopathy of prematurity--risk factors.
    Indian journal of pediatrics, 2004, Volume: 71, Issue:10

    Topics: Apnea; Female; Humans; Hyaline Membrane Disease; Incidence; India; Infant; Infant, Low Birth Weight;

2004
On the caffeination of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Caffeine; Central Nervous System Stimulants; Developmental Disabilities; Humans; Infant, Newb

2007
Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China.
    The British journal of ophthalmology, 2008, Volume: 92, Issue:3

    Topics: Abruptio Placentae; Anemia; Apnea; Birth Weight; China; Female; Gestational Age; Humans; Hypoxia-Isc

2008
Retinopathy of prematurity: incidence and risk factors.
    Pediatrics, 1983, Volume: 72, Issue:2

    Topics: Apnea; Carbon Dioxide; Female; Humans; Hypoxia; Infant, Low Birth Weight; Infant, Newborn; Male; Oxy

1983
Risk factors for retrolental fibroplasia.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1983, Volume: 186, Issue:4

    Topics: Apnea; Exchange Transfusion, Whole Blood; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant,

1983
Acute proliferative retrolental fibroplasia: multivariate risk analysis.
    Transactions of the American Ophthalmological Society, 1983, Volume: 81

    Topics: Analysis of Variance; Anemia; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Cerebral Hemorrhage;

1983
Risk factors in retrolental fibroplasia.
    Pediatrics, 1980, Volume: 65, Issue:6

    Topics: Apnea; Birth Weight; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, D

1980
Blood transfusion: a possible risk factor in retrolental fibroplasia.
    Acta paediatrica Scandinavica, 1981, Volume: 70, Issue:4

    Topics: Apnea; Diseases in Twins; Exchange Transfusion, Whole Blood; Humans; Infant, Low Birth Weight; Infan

1981
Retinopathy of prematurity: incidence and risk factors.
    Indian pediatrics, 1996, Volume: 33, Issue:12

    Topics: Analysis of Variance; Anemia; Apnea; Blood Transfusion; Cohort Studies; Cryosurgery; Follow-Up Studi

1996
Sequelae of caffeine treatment in preterm infants with apnea.
    The Journal of pediatrics, 1979, Volume: 94, Issue:1

    Topics: Apnea; Caffeine; Child Development; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Inf

1979
[Present status of retrolental fibroplasia in France].
    Archives francaises de pediatrie, 1979, Volume: 36, Issue:6

    Topics: Apnea; Body Weight; France; Humans; Infant, Newborn; Infant, Premature, Diseases; Oxygen; Retinopath

1979
Mechanical ventilation of infants of less than 1,501 gm birth weight: Health, growth, and neurologic sequelae.
    The Journal of pediatrics, 1976, Volume: 88, Issue:4 Pt 1

    Topics: Apnea; Birth Weight; Body Height; Child, Preschool; Female; Follow-Up Studies; Growth; Hemiplegia; H

1976
Respiratory complications associated with cryotherapy in premature infants.
    American journal of perinatology, 1992, Volume: 9, Issue:4

    Topics: Apnea; Bradycardia; Cryosurgery; Humans; Infant; Infant, Newborn; Positive-Pressure Respiration; Ret

1992
Respiratory outcome in extremely premature infants following ketamine anaesthesia.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1991, Volume: 38, Issue:3

    Topics: Age Factors; Aminophylline; Anesthesia, Intravenous; Apnea; Birth Weight; Gestational Age; Humans; I

1991
Outcome of preterm infants who suffered neonatal apnoeic attacks.
    Early human development, 1988, Volume: 16, Issue:2-3

    Topics: Apnea; Child, Preschool; Deafness; Developmental Disabilities; Humans; Infant; Infant, Newborn; Infa

1988
Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. National Collaborative Study on Patent Ductus Arteriosus in Premature Infants.
    Pediatrics, 1985, Volume: 76, Issue:3

    Topics: Anemia; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Female; Histamine H1 Antagonists; Humans; I

1985
Consequences of retinopathy of prematurity examinations. Case report.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1987, Volume: 105, Issue:5

    Topics: Apnea; Female; Humans; Infant, Newborn; Ophthalmoscopy; Retinopathy of Prematurity

1987
Occurrence of retinopathy of prematurity in a very low birthweight population.
    Irish medical journal, 1985, Volume: 78, Issue:9

    Topics: Apnea; Humans; Infant, Low Birth Weight; Infant, Newborn; Respiration, Artificial; Retinopathy of Pr

1985
Transient cataracts in low-birth-weight infants.
    The Journal of pediatrics, 1973, Volume: 82, Issue:2

    Topics: Acidosis; Ampicillin; Apgar Score; Apnea; Bicarbonates; Birth Weight; Blood Pressure; Body Temperatu

1973
Ocular changes in premature babies receiving controlled oxygen therapy in the neonatal period.
    Proceedings of the Royal Society of Medicine, 1971, Volume: 64, Issue:7

    Topics: Apnea; Humans; Infant, Newborn; Infant, Premature, Diseases; Ophthalmoscopy; Oxygen; Oxygen Inhalati

1971